Back to Search

ACLX

Arcellx, Inc. Common Stock
Data: 2026-03-30
$114.655
Price
0.07%
Change
$114.91
52W High
$47.8601
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Quick Stats
Mar 30, 2026

57.3

AI Score

HOLD

0.04

Volume Ratio

May 14, 2026

Next Earnings

15

+ve Days (30d)

14

-ve Days (30d)

ACLX Stock Summary

Last updated

ACLX is currently trading at $114.655, positioned above its 200-day moving average of $78.79, indicating a long-term uptrend. The stock has a 52-week range of $47.8601 to $114.91.

Technical Analysis: The 50-day moving average stands at $92.33, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ACLX at 57.3/100 with a HOLD recommendation.

ACLX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ACLX Price vs Max Options Open Interest
ACLX Max Change In Options Open Interest

ACLX Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ACLX Daily Out of Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ACLX Daily In the Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ACLX Most Active Options by Volume(near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Arcellx, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.

ACLX Moving Averages Analysis

Arcellx, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Mar 30, 2026

Arcellx, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Mar 30, 2026

ACLX (Arcellx, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Mar 30, 2026

Days MA
10 114.58
20 114.46
30 108.07
50 92.33
100 83.04
200 78.79

ACLX Fundamental Analysis

P/E (Forward) 61.7284
P/E (Trailing) --
Market Cap ($) 6.7 billion
Earnings/Share ($) -4.07
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -4.2198
EPS Estimate Next Year ($) -1.7304
WallStreet Target Price ($) 111.0714
Most Recent Quarter